FIELD: medicine.
SUBSTANCE: invention represents a pharmaceutical composition containing bacteriophage (Sextaphage® (Pyobacteriophage Polyvalent)) or Bacteriophage Salmonellous groups A, B, C, D, E) dried up with excipients (methyl cellulose, lactose, calcium carbonate, calcium or magnesium stearate) in the form of gastric-resistant uncoated tablets, differing by the fact that the relation of parity bacteriophage to excipients makes 1:1 to 1.25:1, and the composition contains in addition - sorbite and sodium alginate. One tablet of weight 0.16-0.2 g contains bacteriophages with Appelman titre not less than 10-3, and the ingredients of the components are in a certain ratio, wt %.
EFFECT: higher gastric resistance of tablets and stabilisation of bacteriophages.
2 cl, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| ANTIBACTERIAL PHARMACEUTICAL COMPOSITION FOR ORAL USE CONTAINING BACTERIOPHAGES | 2016 |
|
RU2660355C2 |
| PHARMACEUTICAL COMPOSITION FOR TREATMENT AND PROPHYLAXIS OF BACTERIAL INFECTION | 2012 |
|
RU2520346C2 |
| BACTERIOPHAGE-CONTAINING PHARMACEUTICAL COMPOSITION AND METHOD FOR ITS PREPARING | 2002 |
|
RU2241446C2 |
| BIOPHARMACEUTICAL COMPOSITION WITH ANTIBACTERIAL AND PROBIOTIC ACTIVITY AND DOSAGE FORM BASED ON IT | 2021 |
|
RU2795770C2 |
| IMMUNOBIOLOGICAL BACTERICIDAL PREPARATION (VERSIONS) | 2007 |
|
RU2366708C2 |
| ANTIBACTERIAL COMPOSITION FOR PREVENTION OR TREATMENT OF HOSPITAL INFECTIONS (VERSIONS), BACTERIOPHAGE STAMPS USED TO OBTAIN SUCH COMPOSITION | 2015 |
|
RU2628312C2 |
| PREPARATION FOR TREATMENT OF PATIENT WITH SUPPURATIVE-INFLAMMATORY DISEASES (VARIANTS) | 1997 |
|
RU2144368C1 |
| ENTEROSORBENT | 2005 |
|
RU2279278C2 |
| BACTERIOPHAGE COMPOSITION (VERSIONS) | 2007 |
|
RU2366437C2 |
| METHOD FOR PREPARING POLYBACTERIOPHAGE | 2002 |
|
RU2247151C2 |
